Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib (Q39979504)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib |
scientific article |
Statements
1 reference
Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib (English)
1 reference
John C McKew
1 reference
Katherine L Lee
1 reference
Marina W H Shen
1 reference
Paresh Thakker
1 reference
Megan A Foley
1 reference
Mark L Behnke
1 reference
Baihua Hu
1 reference
Fuk-Wah Sum
1 reference
Steve Tam
1 reference
Yonghan Hu
1 reference
Lihren Chen
1 reference
Steven J Kirincich
1 reference
Ronald Michalak
1 reference
Jennifer Thomason
1 reference
Manus Ipek
1 reference
Kun Wu
1 reference
Lane Wooder
1 reference
Manjunath K Ramarao
1 reference
Elizabeth A Murphy
1 reference
Debra G Goodwin
1 reference
Leo Albert
1 reference
Xin Xu
1 reference
Frances Donahue
1 reference
M Sherry Ku
1 reference
James Keith
1 reference
Cheryl L Nickerson-Nutter
1 reference
William M Abraham
1 reference
Cara Williams
1 reference
Martin Hegen
1 reference
James D Clark
1 reference
23 May 2008
1 reference
1 reference
51
1 reference
12
1 reference
3388-3413
1 reference
Identifiers
1 reference
1 reference